CDKAL1 Activators encompass a diverse array of chemical compounds that indirectly enhance the functional activity of CDKAL1 through various signaling pathways and molecular interactions. ATP is fundamental for CDKAL1's kinase activity, providing the necessary phosphate groups, while the presence of essential cofactors like Mg2+ and Zn2+ is critical for its structural stability and substrate interactions. Inhibition of competitive binding sites by CDK inhibitors such as Roscovitine may bolster CDKAL1's phosphorylation events, thereby amplifying its role in cellular processes. Similarly, Forskolin's ability to raise cAMP levels indirectly promotes CDKAL1 activity through PKA-mediated pathways, which might affect CDKAL1's regulation of the cell cycle. The use of phosphatase like Sodium orthovanadate ensures the preservation of CDKAL1's phosphorylated substrates, thereby sustaining its function within the cell.
Moreover, compounds such as Retinoic acid and Trichostatin A (TSA) modulate cellular differentiation and chromatin structure, respectively, which could create a conducive environment for enhanced CDKAL1 activity. The modulation of the cellular redox state by NAD+ levels is another avenue through which CDKAL1's enzymatic function might be augmented. The impact of SP600125 on JNK signaling and LY294002 on PI3K/AKT pathways represents further indirect mechanisms by which CDKAL1 activity could be upregulated, considering its involvement in cell growth and proliferation. Lastly, 5-Azacytidine's role in altering geneexpression patterns may lead to an upsurge in proteins that govern or interact with CDKAL1, facilitating an increase in its functional activity. Collectively, these activators, through their targeted biochemical actions, support the enhancement of CDKAL1-mediated functions critical for cellular homeostasis and proliferation, without the need to directly upregulate its expression or activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine, a CDK inhibitor, can indirectly increase CDKAL1 activity by reducing competitive binding sites and shifting balance towards CDKAL1's involvement in phosphorylation events. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels which could enhance CDKAL1 activity through cAMP-dependent protein kinase (PKA) pathways indirectly affecting CDKAL1's role in cell cycle regulation. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
As a phosphatase inhibitor, sodium orthovanadate prevents dephosphorylation, indirectly maintaining CDKAL1's function by preserving the phosphorylation state of its substrates. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences cell cycle progression and differentiation, pathways in which CDKAL1 plays a role, potentially enhancing its activity in these processes. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zn2+ can act as a cofactor for many proteins, possibly enhancing the structural stability or interaction of CDKAL1 with its substrates or associated proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA, an HDAC inhibitor, changes the acetylation state of proteins, which could alter the interaction landscape of CDKAL1, potentially enhancing its activity. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is essential for redox reactions, and its altered levels could influence CDKAL1 activity by changing the cellular redox state, affecting its enzymatic function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 could alter cell signaling pathways, potentially leading to an indirect increase in CDKAL1 activity by shifting the balance of kinase activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY294002 can affect downstream AKT signaling, indirectly influencing CDKAL1's role in cell growth and proliferation pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor can change gene expression patterns, potentially increasing the expression of proteins that interact with or regulate CDKAL1, enhancing its activity. | ||||||